Skip to main content
. 2022 Apr 15;14(4):866. doi: 10.3390/pharmaceutics14040866

Figure 2.

Figure 2

Active and passive targeting approaches in cancer nanotherapeutics. Reproduced from Ref. [32], (2022), with permission from American Chemical Society (ACS).